CEND-1

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CEND-1, covering 2024-08-28 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab [Phase 1, Phase 2]